Transcription	NN	B-NP	B-protein	Other	###	1	Transcription	Transcription	NN	NN	_	2	compound	_	_
factors	NNS	I-NP	I-protein	Other	###	2	factors	factors	NNS	NNS	_	0	root	_	_
as	IN	B-PP	O	Other	###	3	as	as	IN	IN	_	4	case	_	_
targets	NNS	B-NP	O	Other	###	4	targets	targets	NNS	NNS	_	2	nmod	_	_
for	IN	B-PP	O	Other	###	5	for	for	IN	IN	_	7	case	_	_
oxidative	JJ	B-NP	O	Other	###	6	oxidative	oxidative	JJ	JJ	_	7	amod	_	_
signalling	NN	I-NP	O	Other	###	7	signalling	signalling	NN	NN	_	4	nmod	_	_
during	IN	B-PP	O	Other	###	8	during	during	IN	IN	_	10	case	_	_
lymphocyte	NN	B-NP	O	Other	###	9	lymphocyte	lymphocyte	NN	NN	_	10	compound	_	_
activation	NN	I-NP	O	Other	###	10	activation	activation	NN	NN	_	7	nmod	_	_
.	.	O	O	Other	###	11	.	.	.	.	_	2	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	4	nsubj	_	_
previously	RB	B-ADVP	O	Other	###	2	previously	previously	RB	RB	_	4	advmod	_	_
have	VBP	B-VP	O	Other	###	3	have	have	VBP	VBP	_	4	aux	_	_
demonstrated	VBN	I-VP	O	Other	###	4	demonstrated	demonstrated	VBN	VBN	_	0	root	_	_
a	DT	B-NP	O	Other	###	5	a	a	DT	DT	_	6	det	_	_
requirement	NN	I-NP	O	Other	###	6	requirement	requirement	NN	NN	_	4	dobj	_	_
for	IN	B-PP	O	Other	###	7	for	for	IN	IN	_	9	case	_	_
oxidative	JJ	B-NP	O	Other	###	8	oxidative	oxidative	JJ	JJ	_	9	amod	_	_
events	NNS	I-NP	O	Other	###	9	events	events	NNS	NNS	_	6	nmod	_	_
during	IN	B-PP	O	Other	###	10	during	during	IN	IN	_	13	case	_	_
cell	NN	B-NP	O	Other	###	11	cell	cell	NN	NN	_	13	compound	_	_
cycle	NN	I-NP	O	Other	###	12	cycle	cycle	NN	NN	_	13	compound	_	_
entry	NN	I-NP	O	Other	###	13	entry	entry	NN	NN	_	6	nmod	_	_
in	IN	B-PP	O	Other	###	14	in	in	IN	IN	_	16	case	_	_
T	NN	B-NP	B-cell_type	Other	###	15	T	T	NN	NN	_	16	compound	_	_
lymphocytes	NNS	I-NP	I-cell_type	Other	###	16	lymphocytes	lymphocytes	NNS	NNS	_	13	nmod	_	_
and	CC	O	O	Other	###	17	and	and	CC	CC	_	4	cc	_	_
have	VBP	B-VP	O	Other	###	18	have	have	VBP	VBP	_	19	aux	_	_
hypothesised	VBN	I-VP	O	Other	###	19	hypothesised	hypothesised	VBN	VBN	_	4	conj	_	_
that	IN	B-SBAR	O	Other	###	20	that	that	IN	IN	_	25	mark	_	_
reactive	JJ	B-NP	O	Other	###	21	reactive	reactive	JJ	JJ	_	23	amod	_	_
oxygen	NN	I-NP	O	Other	###	22	oxygen	oxygen	NN	NN	_	23	compound	_	_
species	NNS	I-NP	O	Other	###	23	species	species	NNS	NNS	_	25	nsubj	_	_
may	MD	B-VP	O	Other	###	24	may	may	MD	MD	_	25	aux	_	_
act	VB	I-VP	O	Other	###	25	act	act	VB	VB	_	19	ccomp	_	_
as	IN	B-PP	O	Other	###	26	as	as	IN	IN	_	29	case	_	_
intracellular	JJ	B-NP	O	Other	###	27	intracellular	intracellular	JJ	JJ	_	29	amod	_	_
signalling	NN	I-NP	O	Other	###	28	signalling	signalling	NN	NN	_	29	compound	_	_
agents	NNS	I-NP	O	Other	###	29	agents	agents	NNS	NNS	_	25	nmod	_	_
during	IN	B-PP	O	Other	###	30	during	during	IN	IN	_	32	case	_	_
lymphocyte	NN	B-NP	O	Other	###	31	lymphocyte	lymphocyte	NN	NN	_	32	compound	_	_
activation	NN	I-NP	O	Other	###	32	activation	activation	NN	NN	_	25	nmod	_	_
.	.	O	O	Other	###	33	.	.	.	.	_	4	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	4	case	_	_
the	DT	B-NP	O	Other	###	2	the	the	DT	DT	_	4	det	_	_
current	JJ	I-NP	O	Other	###	3	current	current	JJ	JJ	_	4	amod	_	_
study	NN	I-NP	O	Other	###	4	study	study	NN	NN	_	17	nmod	_	_
,	,	O	O	Other	###	5	,	,	,	,	_	17	punct	_	_
cysteamine	NN	B-NP	O	Other	###	6	cysteamine	cysteamine	NN	NN	_	17	nsubjpass	_	_
,	,	O	O	Other	###	7	,	,	,	,	_	6	punct	_	_
an	DT	B-NP	O	Other	###	8	an	an	DT	DT	_	10	det	_	_
aminothiol	NN	I-NP	O	Other	###	9	aminothiol	aminothiol	NN	NN	_	10	compound	_	_
compound	NN	I-NP	O	Other	###	10	compound	compound	NN	NN	_	6	appos	_	_
with	IN	B-PP	O	Other	###	11	with	with	IN	IN	_	13	case	_	_
antioxidant	JJ	B-NP	O	Other	###	12	antioxidant	antioxidant	JJ	JJ	_	13	amod	_	_
activity	NN	I-NP	O	Other	###	13	activity	activity	NN	NN	_	10	nmod	_	_
,	,	O	O	Other	###	14	,	,	,	,	_	6	punct	_	_
has	VBZ	B-VP	O	Other	###	15	has	has	VBZ	VBZ	_	17	aux	_	_
been	VBN	I-VP	O	Other	###	16	been	been	VBN	VBN	_	17	auxpass	_	_
used	VBN	I-VP	O	Other	###	17	used	used	VBN	VBN	_	0	root	_	_
to	TO	B-VP	O	Other	###	18	to	to	TO	TO	_	20	mark	_	_
further	RB	I-VP	O	Other	###	19	further	further	RB	RB	_	20	advmod	_	_
investigate	VB	I-VP	O	Other	###	20	investigate	investigate	VB	VB	_	17	xcomp	_	_
the	DT	B-NP	O	Other	###	21	the	the	DT	DT	_	22	det	_	_
role	NN	I-NP	O	Other	###	22	role	role	NN	NN	_	20	dobj	_	_
of	IN	B-PP	O	Other	###	23	of	of	IN	IN	_	25	case	_	_
oxidative	JJ	B-NP	O	Other	###	24	oxidative	oxidative	JJ	JJ	_	25	amod	_	_
signalling	NN	I-NP	O	Other	###	25	signalling	signalling	NN	NN	_	22	nmod	_	_
during	IN	B-PP	O	Other	###	26	during	during	IN	IN	_	28	case	_	_
lymphocyte	NN	B-NP	O	Other	###	27	lymphocyte	lymphocyte	NN	NN	_	28	compound	_	_
activation	NN	I-NP	O	Other	###	28	activation	activation	NN	NN	_	22	nmod	_	_
.	.	O	O	Other	###	29	.	.	.	.	_	17	punct	_	_

Treatment	NN	B-NP	O	Other	###	1	Treatment	Treatment	NN	NN	_	13	nsubjpass	_	_
of	IN	B-PP	O	Other	###	2	of	of	IN	IN	_	7	case	_	_
normal	JJ	B-NP	B-cell_type	Other	###	3	normal	normal	JJ	JJ	_	7	amod	_	_
human	JJ	I-NP	I-cell_type	Other	###	4	human	human	JJ	JJ	_	7	amod	_	_
peripheral	JJ	I-NP	I-cell_type	Other	###	5	peripheral	peripheral	JJ	JJ	_	7	amod	_	_
blood	NN	I-NP	I-cell_type	Other	###	6	blood	blood	NN	NN	_	7	compound	_	_
lymphocytes	NNS	I-NP	I-cell_type	Other	###	7	lymphocytes	lymphocytes	NNS	NNS	_	1	nmod	_	_
with	IN	B-PP	O	Other	###	8	with	with	IN	IN	_	9	case	_	_
cysteamine	NN	B-NP	O	Other	###	9	cysteamine	cysteamine	NN	NN	_	1	nmod	_	_
in	FW	B-ADVP	O	Other	###	10	in	in	FW	FW	_	11	compound	_	_
vitro	FW	I-ADVP	O	Other	###	11	vitro	vitro	FW	FW	_	1	advmod	_	_
was	VBD	B-VP	O	Other	###	12	was	was	VBD	VBD	_	13	auxpass	_	_
found	VBN	I-VP	O	Other	###	13	found	found	VBN	VBN	_	0	root	_	_
to	TO	I-VP	O	Other	###	14	to	to	TO	TO	_	15	mark	_	_
inhibit	VB	I-VP	O	Other	###	15	inhibit	inhibit	VB	VB	_	13	xcomp	_	_
proliferation	NN	B-NP	O	Other	###	16	proliferation	proliferation	NN	NN	_	15	dobj	_	_
in	IN	B-PP	O	Other	###	17	in	in	IN	IN	_	22	case	_	_
a	DT	B-NP	O	Other	###	18	a	a	DT	DT	_	22	det	_	_
dose	JJ	I-NP	O	Other	###	19	dose	dose	JJ	JJ	_	22	amod	_	_
-	-	O	O	Other	###	20	-	-	-	-	_	19	punct	_	_
dependent	JJ	I-NP	O	Other	###	21	dependent	dependent	JJ	JJ	_	19	dep	_	_
manner	NN	I-NP	O	Other	###	22	manner	manner	NN	NN	_	15	nmod	_	_
,	,	O	O	Other	###	23	,	,	,	,	_	15	punct	_	_
with	IN	B-PP	O	Other	###	24	with	with	IN	IN	_	28	mark	_	_
essentially	RB	B-NP	O	Other	###	25	essentially	essentially	RB	RB	_	26	advmod	_	_
complete	JJ	I-NP	O	Other	###	26	complete	complete	JJ	JJ	_	27	amod	_	_
inhibition	NN	I-NP	O	Other	###	27	inhibition	inhibition	NN	NN	_	28	nsubj	_	_
occurring	VBG	B-VP	O	Other	###	28	occurring	occurring	VBG	VBG	_	15	advcl	_	_
at	IN	B-PP	O	Other	###	29	at	at	IN	IN	_	31	case	_	_
a	DT	B-NP	O	Other	###	30	a	a	DT	DT	_	31	det	_	_
dose	NN	I-NP	O	Other	###	31	dose	dose	NN	NN	_	28	nmod	_	_
of	IN	B-PP	O	Other	###	32	of	of	IN	IN	_	34	case	_	_
400	CD	B-NP	O	Other	###	33	400	400	CD	CD	_	34	nummod	_	_
microM	NN	I-NP	O	Other	###	34	microM	microM	NN	NN	_	31	nmod	_	_
.	.	O	O	Other	###	35	.	.	.	.	_	13	punct	_	_

This	DT	B-NP	O	Other	###	1	This	This	DT	DT	_	3	det	_	_
inhibitory	JJ	I-NP	O	Other	###	2	inhibitory	inhibitory	JJ	JJ	_	3	amod	_	_
effect	NN	I-NP	O	Other	###	3	effect	effect	NN	NN	_	5	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	4	was	was	VBD	VBD	_	5	auxpass	_	_
limited	VBN	I-VP	O	Other	###	5	limited	limited	VBN	VBN	_	0	root	_	_
to	TO	B-PP	O	Other	###	6	to	to	TO	TO	_	10	case	_	_
the	DT	B-NP	O	Other	###	7	the	the	DT	DT	_	10	det	_	_
first	JJ	I-NP	O	Other	###	8	first	first	JJ	JJ	_	10	amod	_	_
2	CD	I-NP	O	Other	###	9	2	2	CD	CD	_	10	nummod	_	_
h	NN	I-NP	O	Other	###	10	h	h	NN	NN	_	5	nmod	_	_
after	IN	B-PP	O	Other	###	11	after	after	IN	IN	_	13	case	_	_
mitogenic	JJ	B-NP	O	Other	###	12	mitogenic	mitogenic	JJ	JJ	_	13	amod	_	_
activation	NN	I-NP	O	Other	###	13	activation	activation	NN	NN	_	10	nmod	_	_
,	,	O	O	Other	###	14	,	,	,	,	_	5	punct	_	_
localizing	VBG	B-VP	O	Other	###	15	localizing	localizing	VBG	VBG	_	5	xcomp	_	_
the	DT	B-NP	O	Other	###	16	the	the	DT	DT	_	17	det	_	_
time-frame	NN	I-NP	O	Other	###	17	time-frame	time-frame	NN	NN	_	15	dobj	_	_
of	IN	B-PP	O	Other	###	18	of	of	IN	IN	_	19	case	_	_
action	NN	B-NP	O	Other	###	19	action	action	NN	NN	_	17	nmod	_	_
of	IN	B-PP	O	Other	###	20	of	of	IN	IN	_	21	case	_	_
cysteamine	NN	B-NP	O	Other	###	21	cysteamine	cysteamine	NN	NN	_	19	nmod	_	_
to	TO	B-PP	O	Other	###	22	to	to	TO	TO	_	26	case	_	_
within	IN	B-PP	O	Other	###	23	within	within	IN	IN	_	26	case	_	_
the	DT	B-NP	O	Other	###	24	the	the	DT	DT	_	26	det	_	_
commitment	NN	I-NP	O	Other	###	25	commitment	commitment	NN	NN	_	26	compound	_	_
period	NN	I-NP	O	Other	###	26	period	period	NN	NN	_	15	advcl	_	_
.	.	O	O	Other	###	27	.	.	.	.	_	5	punct	_	_

It	PRP	B-NP	O	Other	###	1	It	It	PRP	PRP	_	5	nsubj	_	_
therefore	RB	B-ADVP	O	Other	###	2	therefore	therefore	RB	RB	_	5	advmod	_	_
was	VBD	B-VP	O	Other	###	3	was	was	VBD	VBD	_	5	cop	_	_
of	IN	B-PP	O	Other	###	4	of	of	IN	IN	_	5	case	_	_
interest	NN	B-NP	O	Other	###	5	interest	interest	NN	NN	_	0	root	_	_
to	TO	B-VP	O	Other	###	6	to	to	TO	TO	_	7	mark	_	_
establish	VB	I-VP	O	Other	###	7	establish	establish	VB	VB	_	5	xcomp	_	_
which	WDT	B-NP	O	Other	###	8	which	which	WDT	WDT	_	16	dobj	_	_
,	,	O	O	Other	###	9	,	,	,	,	_	16	punct	_	_
if	IN	B-PP	O	Other	###	10	if	if	IN	IN	_	11	mark	_	_
any	DT	B-NP	O	Other	###	11	any	any	DT	DT	_	16	advcl	_	_
,	,	O	O	Other	###	12	,	,	,	,	_	16	punct	_	_
commitment	NN	B-NP	O	Other	###	13	commitment	commitment	NN	NN	_	14	compound	_	_
events	NNS	I-NP	O	Other	###	14	events	events	NNS	NNS	_	16	nsubjpass	_	_
were	VBD	B-VP	O	Other	###	15	were	were	VBD	VBD	_	16	auxpass	_	_
affected	VBN	I-VP	O	Other	###	16	affected	affected	VBN	VBN	_	7	ccomp	_	_
by	IN	B-PP	O	Other	###	17	by	by	IN	IN	_	19	case	_	_
oxidative	JJ	B-NP	O	Other	###	18	oxidative	oxidative	JJ	JJ	_	19	amod	_	_
signalling	NN	I-NP	O	Other	###	19	signalling	signalling	NN	NN	_	16	nmod	_	_
during	IN	B-PP	O	Other	###	20	during	during	IN	IN	_	23	case	_	_
cell	NN	B-NP	O	Other	###	21	cell	cell	NN	NN	_	23	compound	_	_
cycle	NN	I-NP	O	Other	###	22	cycle	cycle	NN	NN	_	23	compound	_	_
entry	NN	I-NP	O	Other	###	23	entry	entry	NN	NN	_	19	nmod	_	_
.	.	O	O	Other	###	24	.	.	.	.	_	5	punct	_	_

Taking	VBG	B-VP	O	Other	###	1	Taking	Taking	VBG	VBG	_	0	root	_	_
the	DT	B-NP	O	Other	###	2	the	the	DT	DT	_	4	det	_	_
IL-2	NN	I-NP	B-DNA	B-Protein	###	3	IL-2	IL-2	NN	NN	_	4	compound	_	_
gene	NN	I-NP	I-DNA	Other	###	4	gene	gene	NN	NN	_	1	dobj	_	_
as	IN	B-PP	O	Other	###	5	as	as	IN	IN	_	7	case	_	_
a	DT	B-NP	O	Other	###	6	a	a	DT	DT	_	7	det	_	_
candidate	NN	I-NP	O	Other	###	7	candidate	candidate	NN	NN	_	1	nmod	_	_
,	,	O	O	Other	###	8	,	,	,	,	_	1	punct	_	_
we	PRP	B-NP	O	Other	###	9	we	we	PRP	PRP	_	10	nsubj	_	_
examined	VBD	B-VP	O	Other	###	10	examined	examined	VBD	VBD	_	1	parataxis	_	_
the	DT	B-NP	O	Other	###	11	the	the	DT	DT	_	12	det	_	_
effect	NN	I-NP	O	Other	###	12	effect	effect	NN	NN	_	10	dobj	_	_
of	IN	B-PP	O	Other	###	13	of	of	IN	IN	_	15	case	_	_
cysteamine	NN	B-NP	O	Other	###	14	cysteamine	cysteamine	NN	NN	_	15	compound	_	_
treatment	NN	I-NP	O	Other	###	15	treatment	treatment	NN	NN	_	12	nmod	_	_
on	IN	B-PP	O	Other	###	16	on	on	IN	IN	_	19	case	_	_
early	JJ	B-NP	B-DNA	Other	###	17	early	early	JJ	JJ	_	18	amod	_	_
gene	NN	I-NP	I-DNA	Other	###	18	gene	gene	NN	NN	_	19	compound	_	_
expression	NN	I-NP	O	Other	###	19	expression	expression	NN	NN	_	12	nmod	_	_
during	IN	B-PP	O	Other	###	20	during	during	IN	IN	_	22	case	_	_
lymphocyte	NN	B-NP	O	Other	###	21	lymphocyte	lymphocyte	NN	NN	_	22	compound	_	_
activation	NN	I-NP	O	Other	###	22	activation	activation	NN	NN	_	19	nmod	_	_
,	,	B-PP	O	Other	###	23	,	,	,	,	_	19	punct	_	_
and	CC	I-PP	O	Other	###	24	and	and	CC	CC	_	19	cc	_	_
on	IN	B-PP	O	Other	###	25	on	on	IN	IN	_	27	case	_	_
the	DT	B-NP	O	Other	###	26	the	the	DT	DT	_	27	det	_	_
activity	NN	I-NP	O	Other	###	27	activity	activity	NN	NN	_	19	conj	_	_
of	IN	B-PP	O	Other	###	28	of	of	IN	IN	_	30	case	_	_
transcription	NN	B-NP	B-protein	Other	###	29	transcription	transcription	NN	NN	_	30	compound	_	_
factors	NNS	I-NP	I-protein	Other	###	30	factors	factors	NNS	NNS	_	27	nmod	_	_
AP-1	NN	B-NP	B-protein	Other	###	31	AP-1	AP-1	NN	NN	_	30	dep	_	_
,	,	O	O	Other	###	32	,	,	,	,	_	31	punct	_	_
NF-kappa	NN	B-NP	B-protein	Other	###	33	NF-kappa	NF-kappa	NN	NN	_	34	compound	_	_
B	NN	I-NP	I-protein	Other	###	34	B	B	NN	NN	_	31	conj	_	_
,	,	O	O	Other	###	35	,	,	,	,	_	31	punct	_	_
NF-AT	NN	B-NP	B-protein	Other	###	36	NF-AT	NF-AT	NN	NN	_	31	conj	_	_
and	CC	O	O	Other	###	37	and	and	CC	CC	_	31	cc	_	_
Oct1	NN	B-NP	B-protein	B-Protein	###	38	Oct1	Oct1	NN	NN	_	31	conj	_	_
,	,	O	O	Other	###	39	,	,	,	,	_	30	punct	_	_
whose	WP$	B-NP	O	Other	###	40	whose	whose	WP$	WP$	_	41	nmod:poss	_	_
functions	NNS	I-NP	O	Other	###	41	functions	functions	NNS	NNS	_	43	nsubjpass	_	_
are	VBP	B-VP	O	Other	###	42	are	are	VBP	VBP	_	43	auxpass	_	_
required	VBN	I-VP	O	Other	###	43	required	required	VBN	VBN	_	30	acl:relcl	_	_
for	IN	B-PP	O	Other	###	44	for	for	IN	IN	_	45	case	_	_
expression	NN	B-NP	O	Other	###	45	expression	expression	NN	NN	_	43	nmod	_	_
of	IN	B-PP	O	Other	###	46	of	of	IN	IN	_	49	case	_	_
the	DT	B-NP	O	Other	###	47	the	the	DT	DT	_	49	det	_	_
IL-2	NN	I-NP	B-RNA	B-Protein	###	48	IL-2	IL-2	NN	NN	_	49	compound	_	_
mRNA	NN	I-NP	I-RNA	Other	###	49	mRNA	mRNA	NN	NN	_	45	nmod	_	_
.	.	O	O	Other	###	50	.	.	.	.	_	1	punct	_	_

Cysteamine	NN	B-NP	O	Other	###	1	Cysteamine	Cysteamine	NN	NN	_	2	compound	_	_
treatment	NN	I-NP	O	Other	###	2	treatment	treatment	NN	NN	_	3	nsubj	_	_
inhibited	VBD	B-VP	O	Other	###	3	inhibited	inhibited	VBD	VBD	_	0	root	_	_
both	CC	O	O	Other	###	4	both	both	CC	CC	_	5	cc:preconj	_	_
expression	NN	B-NP	O	Other	###	5	expression	expression	NN	NN	_	3	dobj	_	_
of	IN	B-PP	O	Other	###	6	of	of	IN	IN	_	9	case	_	_
the	DT	B-NP	O	Other	###	7	the	the	DT	DT	_	9	det	_	_
IL-2	NN	I-NP	B-RNA	B-Protein	###	8	IL-2	IL-2	NN	NN	_	9	compound	_	_
mRNA	NN	I-NP	I-RNA	Other	###	9	mRNA	mRNA	NN	NN	_	5	nmod	_	_
and	CC	O	O	Other	###	10	and	and	CC	CC	_	5	cc	_	_
secretion	NN	B-NP	O	Other	###	11	secretion	secretion	NN	NN	_	5	conj	_	_
of	IN	B-PP	O	Other	###	12	of	of	IN	IN	_	13	case	_	_
IL-2	NN	B-NP	B-protein	B-Protein	###	13	IL-2	IL-2	NN	NN	_	11	nmod	_	_
into	IN	B-PP	O	Other	###	14	into	into	IN	IN	_	17	case	_	_
the	DT	B-NP	O	Other	###	15	the	the	DT	DT	_	17	det	_	_
culture	NN	I-NP	O	Other	###	16	culture	culture	NN	NN	_	17	compound	_	_
medium	NN	I-NP	O	Other	###	17	medium	medium	NN	NN	_	5	nmod	_	_
.	.	O	O	Other	###	18	.	.	.	.	_	3	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	3	det	_	_
inhibitory	JJ	I-NP	O	Other	###	2	inhibitory	inhibitory	JJ	JJ	_	3	amod	_	_
effect	NN	I-NP	O	Other	###	3	effect	effect	NN	NN	_	8	nsubjpass	_	_
of	IN	B-PP	O	Other	###	4	of	of	IN	IN	_	5	case	_	_
cysteamine	NN	B-NP	O	Other	###	5	cysteamine	cysteamine	NN	NN	_	3	nmod	_	_
may	MD	B-VP	O	Other	###	6	may	may	MD	MD	_	8	aux	_	_
be	VB	I-VP	O	Other	###	7	be	be	VB	VB	_	8	auxpass	_	_
mediated	VBN	I-VP	O	Other	###	8	mediated	mediated	VBN	VBN	_	0	root	_	_
at	IN	B-ADVP	O	Other	###	9	at	at	IN	IN	_	12	advmod	_	_
least	JJS	I-ADVP	O	Other	###	10	least	least	JJS	JJS	_	9	mwe	_	_
in	IN	B-PP	O	Other	###	11	in	in	IN	IN	_	12	case	_	_
part	NN	B-NP	O	Other	###	12	part	part	NN	NN	_	8	nmod	_	_
by	IN	B-PP	O	Other	###	13	by	by	IN	IN	_	15	case	_	_
an	DT	B-NP	O	Other	###	14	an	an	DT	DT	_	15	det	_	_
effect	NN	I-NP	O	Other	###	15	effect	effect	NN	NN	_	8	nmod	_	_
on	IN	B-PP	O	Other	###	16	on	on	IN	IN	_	19	case	_	_
transcription	NN	B-NP	B-protein	Other	###	17	transcription	transcription	NN	NN	_	19	compound	_	_
factor	NN	I-NP	I-protein	Other	###	18	factor	factor	NN	NN	_	19	compound	_	_
function	NN	I-NP	O	Other	###	19	function	function	NN	NN	_	15	nmod	_	_
,	,	O	O	Other	###	20	,	,	,	,	_	8	punct	_	_
as	IN	B-SBAR	O	Other	###	21	as	as	IN	IN	_	39	mark	_	_
the	DT	B-NP	O	Other	###	22	the	the	DT	DT	_	25	det	_	_
DNA	NN	I-NP	O	Other	###	23	DNA	DNA	NN	NN	_	25	compound	_	_
binding	NN	I-NP	O	Other	###	24	binding	binding	NN	NN	_	25	compound	_	_
activities	NNS	I-NP	O	Other	###	25	activities	activities	NNS	NNS	_	39	nsubjpass	_	_
of	IN	B-PP	O	Other	###	26	of	of	IN	IN	_	27	case	_	_
AP-1	NN	B-NP	B-protein	Other	###	27	AP-1	AP-1	NN	NN	_	25	nmod	_	_
and	CC	O	O	Other	###	28	and	and	CC	CC	_	27	cc	_	_
NF-kappa	NN	B-NP	B-protein	Other	###	29	NF-kappa	NF-kappa	NN	NN	_	30	compound	_	_
B	NN	I-NP	I-protein	Other	###	30	B	B	NN	NN	_	27	conj	_	_
extracted	VBN	B-VP	O	Other	###	31	extracted	extracted	VBN	VBN	_	27	acl	_	_
from	IN	B-PP	O	Other	###	32	from	from	IN	IN	_	36	case	_	_
mitogen	JJ	B-NP	B-cell_type	Other	###	33	mitogen	mitogen	JJ	JJ	_	36	amod	_	_
-	-	O	O	Other	###	34	-	-	-	-	_	36	punct	_	_
stimulated	JJ	B-NP	B-cell_type	Other	###	35	stimulated	stimulated	JJ	JJ	_	36	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	###	36	cells	cells	NNS	NNS	_	31	nmod	_	_
were	VBD	B-VP	O	Other	###	37	were	were	VBD	VBD	_	39	auxpass	_	_
significantly	RB	I-VP	O	Other	###	38	significantly	significantly	RB	RB	_	39	advmod	_	_
inhibited	VBN	I-VP	O	Other	###	39	inhibited	inhibited	VBN	VBN	_	8	advcl	_	_
by	IN	B-PP	O	Other	###	40	by	by	IN	IN	_	42	case	_	_
cysteamine	NN	B-NP	O	Other	###	41	cysteamine	cysteamine	NN	NN	_	42	compound	_	_
treatment	NN	I-NP	O	Other	###	42	treatment	treatment	NN	NN	_	39	nmod	_	_
.	.	O	O	Other	###	43	.	.	.	.	_	8	punct	_	_

Interestingly	RB	B-ADVP	O	Other	###	1	Interestingly	Interestingly	RB	RB	_	11	advmod	_	_
,	,	O	O	Other	###	2	,	,	,	,	_	11	punct	_	_
Oct1	NN	B-NP	B-protein	B-Protein	###	3	Oct1	Oct1	NN	NN	_	8	compound	_	_
and	CC	I-NP	O	Other	###	4	and	and	CC	CC	_	3	cc	_	_
NF-AT	NN	I-NP	B-protein	Other	###	5	NF-AT	NF-AT	NN	NN	_	3	conj	_	_
DNA	NN	I-NP	O	Other	###	6	DNA	DNA	NN	NN	_	8	compound	_	_
binding	NN	I-NP	O	Other	###	7	binding	binding	NN	NN	_	8	compound	_	_
activity	NN	I-NP	O	Other	###	8	activity	activity	NN	NN	_	11	nsubjpass	_	_
were	VBD	B-VP	O	Other	###	9	were	were	VBD	VBD	_	11	auxpass	_	_
not	RB	I-VP	O	Other	###	10	not	not	RB	RB	_	11	neg	_	_
affected	VBN	I-VP	O	Other	###	11	affected	affected	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	###	12	by	by	IN	IN	_	14	case	_	_
cysteamine	NN	B-NP	O	Other	###	13	cysteamine	cysteamine	NN	NN	_	14	compound	_	_
treatment	NN	I-NP	O	Other	###	14	treatment	treatment	NN	NN	_	11	nmod	_	_
,	,	O	O	Other	###	15	,	,	,	,	_	11	punct	_	_
suggesting	VBG	B-VP	O	Other	###	16	suggesting	suggesting	VBG	VBG	_	11	xcomp	_	_
that	IN	B-SBAR	O	Other	###	17	that	that	IN	IN	_	21	mark	_	_
oxidative	JJ	B-NP	O	Other	###	18	oxidative	oxidative	JJ	JJ	_	20	amod	_	_
signalling	NN	I-NP	O	Other	###	19	signalling	signalling	NN	NN	_	20	compound	_	_
processes	NNS	I-NP	O	Other	###	20	processes	processes	NNS	NNS	_	21	nsubj	_	_
operate	VBP	B-VP	O	Other	###	21	operate	operate	VBP	VBP	_	16	ccomp	_	_
in	IN	B-PP	O	Other	###	22	in	in	IN	IN	_	25	case	_	_
a	DT	B-NP	O	Other	###	23	a	a	DT	DT	_	25	det	_	_
selective	JJ	I-NP	O	Other	###	24	selective	selective	JJ	JJ	_	25	amod	_	_
manner	NN	I-NP	O	Other	###	25	manner	manner	NN	NN	_	21	nmod	_	_
.	.	O	O	Other	###	26	.	.	.	.	_	11	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	2	det	_	_
identification	NN	I-NP	O	Other	###	2	identification	identification	NN	NN	_	18	nsubj	_	_
of	IN	B-PP	O	Other	###	3	of	of	IN	IN	_	5	case	_	_
regulatory	JJ	B-NP	B-protein	Other	###	4	regulatory	regulatory	JJ	JJ	_	5	amod	_	_
proteins	NNS	I-NP	I-protein	Other	###	5	proteins	proteins	NNS	NNS	_	2	nmod	_	_
,	,	O	O	Other	###	6	,	,	,	,	_	5	punct	_	_
such	JJ	B-PP	O	Other	###	7	such	such	JJ	JJ	_	10	case	_	_
as	IN	I-PP	O	Other	###	8	as	as	IN	IN	_	7	mwe	_	_
transcription	NN	B-NP	B-protein	Other	###	9	transcription	transcription	NN	NN	_	10	compound	_	_
factors	NNS	I-NP	I-protein	Other	###	10	factors	factors	NNS	NNS	_	5	nmod	_	_
,	,	O	O	Other	###	11	,	,	,	,	_	5	punct	_	_
as	IN	B-SBAR	O	Other	###	12	as	as	IN	IN	_	14	case	_	_
molecular	JJ	B-NP	O	Other	###	13	molecular	molecular	JJ	JJ	_	14	amod	_	_
targets	NNS	I-NP	O	Other	###	14	targets	targets	NNS	NNS	_	2	nmod	_	_
for	IN	B-PP	O	Other	###	15	for	for	IN	IN	_	17	case	_	_
oxidative	JJ	B-NP	O	Other	###	16	oxidative	oxidative	JJ	JJ	_	17	amod	_	_
signalling	NN	I-NP	O	Other	###	17	signalling	signalling	NN	NN	_	14	nmod	_	_
provides	VBZ	B-VP	O	Other	###	18	provides	provides	VBZ	VBZ	_	0	root	_	_
further	JJ	B-NP	O	Other	###	19	further	further	JJ	JJ	_	20	amod	_	_
evidence	NN	I-NP	O	Other	###	20	evidence	evidence	NN	NN	_	18	dobj	_	_
to	TO	B-VP	O	Other	###	21	to	to	TO	TO	_	22	mark	_	_
implicate	VB	I-VP	O	Other	###	22	implicate	implicate	VB	VB	_	20	acl	_	_
oxidative	JJ	B-NP	O	Other	###	23	oxidative	oxidative	JJ	JJ	_	24	amod	_	_
signalling	NN	I-NP	O	Other	###	24	signalling	signalling	NN	NN	_	22	dobj	_	_
as	IN	B-PP	O	Other	###	25	as	as	IN	IN	_	28	mark	_	_
being	VBG	B-VP	O	Other	###	26	being	being	VBG	VBG	_	28	auxpass	_	_
intimately	RB	I-VP	O	Other	###	27	intimately	intimately	RB	RB	_	28	advmod	_	_
involved	VBN	I-VP	O	Other	###	28	involved	involved	VBN	VBN	_	22	advcl	_	_
in	IN	B-PP	O	Other	###	29	in	in	IN	IN	_	35	case	_	_
the	DT	B-NP	O	Other	###	30	the	the	DT	DT	_	35	det	_	_
G0	NN	I-NP	O	Other	###	31	G0	G0	NN	NN	_	35	compound	_	_
to	TO	B-PP	O	Other	###	32	to	to	TO	TO	_	31	dep	_	_
G1	NN	B-NP	O	Other	###	33	G1	G1	NN	NN	_	31	nmod	_	_
phase	NN	I-NP	O	Other	###	34	phase	phase	NN	NN	_	35	compound	_	_
transition	NN	I-NP	O	Other	###	35	transition	transition	NN	NN	_	28	nmod	_	_
in	IN	B-PP	O	Other	###	36	in	in	IN	IN	_	38	case	_	_
T	NN	B-NP	B-cell_type	Other	###	37	T	T	NN	NN	_	38	compound	_	_
lymphocytes	NNS	I-NP	I-cell_type	Other	###	38	lymphocytes	lymphocytes	NNS	NNS	_	35	nmod	_	_
.	.	O	O	Other	###	39	.	.	.	.	_	18	punct	_	_

